U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180961180961Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic MalignanciesCompletedNo Results AvailableBlood Cancer|LeukemiaDrug: cyclosporine|Drug: Thymoglobulin|Drug: mycophenolate mofetil|Drug: g-csfhttps://ClinicalTrials.gov/show/NCT00185640
180962180962Mixed Chimera Allo Transplantation in Multiple MyelomaCompletedNo Results AvailableBlood Cancer|Multiple MyelomaProcedure: autologous then nonmyeloablative allogeneic transplant|Drug: cyclophosphamide|Drug: Melphalan|Drug: cyclosporin|Drug: Mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT00185614
180963180963Internet Diabetes Self-Management WorkshopCompletedNo Results AvailableDiabetes Mellitus, Type 2Behavioral: Internet Diabetes Self-Management Programhttps://ClinicalTrials.gov/show/NCT00185601
180964180964Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic CancerCompletedHas ResultsPancreatic CancerDrug: Vatalanib|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00185588
180965180965Duloxetine for the Treatment of DysthymiaCompletedNo Results AvailableDepressive DisorderDrug: duloxetinehttps://ClinicalTrials.gov/show/NCT00185575
180966180966A Pilot Trial of Adalimumab for the Treatment of OsteoarthritisCompletedNo Results AvailableOsteoarthritisDrug: Adalimumabhttps://ClinicalTrials.gov/show/NCT00185562
180967180967An Interactive Program to Improve Care for Children With CFCompletedNo Results AvailableCystic FibrosisBehavioral: CF. DOChttps://ClinicalTrials.gov/show/NCT00185549
180968180968Effects of Advertising on Young Children's Perception of TasteCompletedNo Results AvailableObesityBehavioral: Packaging and identification of sourcehttps://ClinicalTrials.gov/show/NCT00185536
180969180969Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)CompletedNo Results AvailableLeukemia, Lymphocytic, Acute|Leukemia|Leukemia Acute Promyelocytic Leukemia (APL)|Leukemia Acute Lymphoid Leukemia (ALL)|Leukemia Chronic Myelogenous Leukemia (CML)|Leukemia Acute Myeloid Leukemia (AML)|Leukemia Chronic Lymphocytic Leukemia (CLL)Procedure: Allogeneic hematopoietic cell transplantationhttps://ClinicalTrials.gov/show/NCT00185523
180970180970Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic DermatitisCompletedNo Results AvailableDermatitis, AtopicDrug: Methylprednisolone Aceponate (Advantan, BAY86-4862)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00185510
180971180971Efficacy and Safety Oral Contraceptive StudyCompletedNo Results AvailableContraceptionDrug: YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)https://ClinicalTrials.gov/show/NCT00185484
180972180972Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).CompletedHas ResultsMenopauseDrug: LNG IUShttps://ClinicalTrials.gov/show/NCT00185458
180973180973Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHLCompletedNo Results AvailableNon Hodgkin LymphomaDrug: Fludarabine Phosphate (Fludara)https://ClinicalTrials.gov/show/NCT00185445
180974180974A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring ContraceptionCompletedNo Results AvailableContraceptionDrug: Yasmin|Drug: Marvelonhttps://ClinicalTrials.gov/show/NCT00185419
180975180975Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line ChemotherapyCompletedNo Results AvailableLymphoma, Non-HodgkinBiological: Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)|Other: no treatmenthttps://ClinicalTrials.gov/show/NCT00185393
180976180976Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)CompletedHas ResultsContraceptionDrug: Levonorgestrel IUS (BAY86-5028, G04209B)|Drug: Levonorgestrel IUS (BAY86-5028, G04209C)|Drug: Levonorgestrel IUS (Mirena, BAY86-5028)https://ClinicalTrials.gov/show/NCT00185380
180977180977Comparative Cycle Control EuropeCompletedNo Results AvailableContraceptionDrug: EV/DNG (Qlaira, BAY86-5027, SH T00658K)|Drug: SH D 593 B (Miranova)https://ClinicalTrials.gov/show/NCT00185367
180978180978FC Patch Comparator StudyCompletedNo Results AvailableContraceptionDrug: BAY86-5016, SH P00331F|Drug: SH P00331Nhttps://ClinicalTrials.gov/show/NCT00185354
180979180979Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic PainCompletedNo Results AvailableEndometriosisDrug: CCR1-Antagonist (BAY86-5047, ZK811752, SH T 04268H)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00185341
180980180980Efficacy and Tolerability of Angeliq in Thai WomenCompletedNo Results AvailablePostmenopauseDrug: Estradiol/DRSP (Angeliq, BAY86-4891)https://ClinicalTrials.gov/show/NCT00185328
180981180981Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary HypertensionCompletedNo Results AvailableHypertension, PulmonaryDrug: Ventavis (Iloprost, BAYQ6256)https://ClinicalTrials.gov/show/NCT00185315
180982180982Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic MelanomaCompletedNo Results AvailableMelanomaDrug: MS-275 (BAY86-5274)|Drug: MS-275 (BAY86-5274)https://ClinicalTrials.gov/show/NCT00185302
180983180983Study to Investigate Efficacy and Safety of a New Oral ContraceptiveCompletedNo Results AvailableContraceptionDrug: EV/DNG (Qlaira, BAY86-5027, SH T00658K)https://ClinicalTrials.gov/show/NCT00185289
180984180984Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral ArteriesCompletedNo Results AvailablePeripheral Vascular DiseaseDrug: Gadopentetate dimeglumine (Magnevist, BAY86-4882)|Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882)https://ClinicalTrials.gov/show/NCT00185276
180985180985Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable AnginaActive, not recruitingNo Results AvailableStable AnginaGenetic: AdF5FGF-4 vs. Placebohttps://ClinicalTrials.gov/show/NCT00185263
180986180986Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral CardiomyopathyCompletedNo Results AvailableCardiomyopathies|Heart DiseasesDrug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)|Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00185250
180987180987Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol PatchCompletedNo Results AvailableHot FlashesDrug: Menostar (estradiol transdermal delivery system)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00185237
180988180988Metabolism Study to Investigate the Impact of a Sequential Oral ContraceptiveCompletedNo Results AvailableContraceptionDrug: EV/DNG (Qlaira, BAY86-5027, SH T00658K)|Drug: SH D00264A (Triquilar)https://ClinicalTrials.gov/show/NCT00185224
180989180989BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up StudyCompletedHas ResultsMultiple SclerosisDrug: Interferon beta-1b (Betaseron, BAY86-5046)|Drug: Interferon beta-1b (Betaseron, BAY86-5046)https://ClinicalTrials.gov/show/NCT00185211
180990180990Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)CompletedNo Results AvailableAndrogens (Deficiency)|MaleDrug: Testogel (Testosterone, BAYV001915)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00185198

* Görseller ve İçerik tekif hakkına sahip olabilir